39 results on '"Mirabile, Aurora"'
Search Results
2. Prevalence of Serum Antibody Titers against Core Vaccine Antigens in Italian Cats
3. The Impact of Pain
4. Acute kidney injury and acute kidney disease in high-dose cisplatin-treated head and neck cancer
5. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers
6. Emergency Department Visits among Cancer Patients during SARS-CoV-2 Pandemic
7. MO192: Renal Outcomes in High Dose Cisplatin in Locally Advanced Squamous Cell Cancer of the Head and Neck: A Monocentric Experience
8. Skeletal Muscle Depletion and Major Postoperative Complications in Locally-Advanced Head and Neck Cancer: A Comparison between Ultrasound of Rectus Femoris Muscle and Neck Cross-Sectional Imaging
9. Angiogenesis inhibition in lung cancer: emerging novel strategies
10. P-62 Helical Intensity Modulated Radiotherapy 18 FDG PET guided in locally advanced oropharyngeal cancer: a mono-institutional experience
11. What to Do and What Not to Do in the Management of Cancer Pain: A Physician Survey and Expert Recommendations
12. A CT-Based Radiomic Signature Can Be Prognostic for 10-Months Overall Survival in Metastatic Tumors Treated with Nivolumab: An Exploratory Study
13. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients
14. Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer
15. History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature
16. Uncommon Site of Metastasis and Prolonged Survival in Patients with Anaplastic Thyroid Carcinoma: A Systematic Review of the Literature
17. Low skeletal muscle mass as predictor of postoperative complications and decreased overall survival in locally advanced head and neck squamous cell carcinoma: the role of ultrasound of rectus femoris muscle
18. Prognostic role of pre-treatment magnetic resonance imaging (MRI) radiomic analysis in patients with squamous cell carcinoma of the head and neck (SCCHN).
19. Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence
20. Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker
21. PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review
22. Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck
23. Predictors of Patient-Reported Dysphagia Following IMRT Plus Chemotherapy in Oropharyngeal Cancer
24. Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?
25. Report from European Association for the Study of the Liver: HCC Summit, Geneva, Switzerland, 2–5 February 2017
26. Role of nutrition in incidence and management of cancer therapy-induced diarrhea (CTID): HEAT (Health Eat and Toxicity) prospective interventional study and preliminary data.
27. Oncological supportive-care unit (OSU): An effective toxicity management model.
28. Temporal course and predictive factors of analgesic opioid requirement for chemoradiation-induced oral mucositis in oropharyngeal cancer
29. Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy
30. Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus
31. Evaluation of an every-other-day palonosetron schedule to control emesis in multiple-day high-dose chemotherapy
32. Fentanyl pectin nasal spray as treatment for incident predictable breakthrough pain (BTP) in oral mucositis induced by chemoradiotherapy in head and neck cancer
33. Identification of a gene expression profile associated with progression-free survival (PFS) in relapsed or metastatic (RM) head and neck squamous cell cancer (HNSCC) patients (pts) treated with first-line cetuximab and platinum therapy.
34. Health care-associated infections (HAIs) in head and neck carcinoma (HNC) patients treated with chemotherapy (CT) and/or radiotherapy (RT).
35. Sorafenib in recurrent and/or metastatic salivary gland carcinomas (RMSGCs): An investigator-initiated phase II trial (NCT01703455).
36. Association between salivary cytokine levels and chemoradiotherapy-induced toxicities in head and neck cancer patients.
37. Targeted therapy in head and neck cancer
38. Comment on “Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locally advanced squamous cell carcinoma of the head and neck (SCCHN): A matched pair analysis”, by Rades et coll.
39. MALT lymphoma and Kaposi Sarcoma in an HIV‐negative patient
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.